source
- Biogen to acquire RayThera in up to $1 billion deal for immunology pipelineBiogen announced it will acquire RayThera, a startup founded in 2023, in a deal valued at up to $1 billion. The acquisition gives Biogen access to RayThera’s immunology pipeline, which includes th…
- IRA's Medicare out-of-pocket cap increased access to drugs, study findsMedication usage, particularly for the most expensive drugs, increased significantly shortly after the Medicare annual out-of-pocket cost cap took effect in January 2025, a study published in JAMA…Endpoints · 2mo ago↗ source